Charles Peloquin, PharmD
Jeffrey Starke, MD
Ana Alvarez, MD
In this series on Pediatric TB, the Pediatric ID Board Certifying Examination Content is presented by expert speakers via case-based, interactive webinars. The series goes beyond basic content while following the pediatric ID guidelines and is intended for a diverse audience, including pediatric infectious disease fellows and clinicians who diagnose and treat TB in children.
Target Audience: The course is designated for physicians, nurses, pharmacists, and field staff who interact with pediatric patients.
- Treatment of TB Disease
- Pharmacotherapeutics of TB Drugs
- Infection Control, Source Case and Contact Investigation
As a result of participation in this activity, participants should be able to:
- Understand the general principles of antimicrobial use in TB medications for infants and children, including pharmacokinetic principles of absorption, distribution, metabolism, half-life, clearance, elimination and monitoring for toxicity/efficacy
- Identify high priority groups of infants and children who should be tested and treated for LTBI and active TB disease and interpret results of tests for same
- Recognize the clinical and radiographic manifestations of pulmonary and extrapulmonary TB in infants and children, including lymphadenitis, meningitis & miliary TB
Note: You must register for the training with the Southeastern National TB Center prior to taking the course. There are several courses in this series: TB-285a, TB-285b, TB-285c.
Course Flyer: https://sntc.medicine.ufl.edu/Content/Courses/Downloads/Advanced%20Concepts%20in%20Pediatric%20TB%20Part%203vcxnxjkzs.docx
Keywords: TB, tuberculosis, TB disease, MTB, Mycobacterium tuberculosis, MTB complex, LTBI. latent TB infection, pediatric, children
There are several courses in this series: TB-285a, TB-285b, TB-285c.